Literature DB >> 7007851

Protection of mice against group B Streptococcus type Ia by IgG components of a rabbit antiserum.

P H Cleat, C R Coid.   

Abstract

IgG fractions were separated by ion exchange chromatography on DEAE-cellulose from hyperimmune rabbit sera prepared against a group B streptococcus type Ia mouse-virulent strain. 50 microgram IgG in conjunction with ampicillin (200 mg/kg) protected mice more effectively against a lethal challenge than ampicillin (400 mg/kg) alone or ampicillin (200 mg/kg) combined with gentamicin (10 mg/kg), when administered up to 12 h after infection.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7007851     DOI： 10.1007/bf02123707

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


  10 in total

1.  ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.

Authors:  C B LAURELL
Journal:  Anal Biochem       Date:  1965-02       Impact factor: 3.365

2.  A simple chromatographic method for preparation of gamma globulin.

Authors:  H B LEVY; H A SOBER
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Emergency treatment of group B streptococcal disease.

Authors:  T C Miller
Journal:  Pediatr Clin North Am       Date:  1977-08       Impact factor: 3.278

5.  Penicillin prophylaxis for neonatal group-B streptococcal infection.

Authors:  R S Ramamurthy; S P Pyati; R S Pildes
Journal:  Lancet       Date:  1979-08-04       Impact factor: 79.321

6.  Mouse protection test for group B Streptococcus type III.

Authors:  R S Baltimore; D L Kasper; J Vecchitto
Journal:  J Infect Dis       Date:  1979-07       Impact factor: 5.226

7.  Blood-transfusion in group-B streptococcal sepsis.

Authors:  A O Shigeoka; R T Hall; H R Hill
Journal:  Lancet       Date:  1978-03-25       Impact factor: 79.321

8.  Perinatal immunity to group B beta-hemolytic streptococcus type Ia.

Authors:  P B Stewardson-Krieger; K Albrandt; T Nevin; R R Kretschmer; S P Gotoff
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

9.  Antibody levels in mothers colonised with group B streptococci during pregnancy and in their newborn infants, as measured by an enzyme linked immunosorbent assay.

Authors:  P H Cleat; J Ross; J R Needham
Journal:  Med Microbiol Immunol       Date:  1980-02       Impact factor: 3.402

10.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.

Authors:  R C Lancefield; M McCarty; W N Everly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307
  10 in total
  7 in total

1.  Passive protection by human sera in mice against challenge with strains of group B streptococci.

Authors:  Y Ichiman; K Yoshida
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

2.  The mode of action of antibody in neutrophil bactericidal activity against highly pathogenic group-B streptococci.

Authors:  P H Cleat; C R Coid
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

3.  An alternative role for specific antibody in neutrophil bactericidal activity against highly pathogenic group B streptococci.

Authors:  P H Cleat; C R Coid
Journal:  Br J Exp Pathol       Date:  1982-08

4.  Isolation, chemical composition, and molecular size of extracellular type II and type Ia polysaccharides of group B streptococci.

Authors:  B J De Cueninck; T F Greber; T K Eisenstein; R M Swenson; G D Shockman
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

5.  Quantitation of in vitro opsonic activity of human antibody induced by a vaccine consisting of the type III-specific polysaccharide of group B streptococcus.

Authors:  B J De Cueninck; T K Eisenstein; T S McIntosh; G D Shockman; R M Swenson
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

6.  Type-specific protection of neonatal rats from lethal group B streptococcal infection by immune sera obtained from human volunteers vaccinated with type III-specific polysaccharide.

Authors:  B J De Cueninck; T K Eisenstein; T S McIntosh; G D Shockman; R M Swenson
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

7.  Phagocytic and bactericidal activity of human neutrophils against two isolates of Group B streptococci Type Ic of differing pathogenicity.

Authors:  P H Cleat; C R Coid
Journal:  Br J Exp Pathol       Date:  1981-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.